Literature DB >> 31321963

Morphological and functional alterations of astrocytes responding to traumatic brain injury.

Xiaoyun Cheng1, Jin Wang2, Xiao Sun2, Lishi Shao1, Zeyun Guo2, Yang Li2.   

Abstract

Astrocytes, one of the most abundant and heterogeneous types of glial cell in the brain and spinal cord, are responsible for various essential functions in the healthy central nervous system, including maintaining the blood brain barrier integrity, regulating neuron differentiation and supporting, nourishing, protecting, insulating and repairing neurons. They also fulfill a range of other homeostatic maintenance functions. Astrocytes are activated after traumatic brain injury. They then exhibit heterogeneous gene expression and changes in morphology, proliferative capacity and various functions in response either acute or chronic brain injury and associated secondary brain injury. Some biomarkers and imaging tools have been used to monitor astrogliosis after traumatic brain injury. Initially, morphological characteristics and the physiology of astrocytes are reviewed. Subsequently, alterations of astrocytes are described, which includes both the complex mechanisms and roles of reactive astrocytes. The roles of biomarkers and signaling pathways following traumatic brain injury have been summarized as well as the morphological and functional changes in astrocytes. In the latter case, by considering astrocytes as therapeutic targets of traumatic brain injury, the mechanisms of the latest drug treatments are explained. This review highlights the beneficial effects of astrogliosis according to some recent findings, which provides new insights for the treatment of traumatic brain injury. ©2019 Cheng et al. Published by IMR press. All rights reserved.

Entities:  

Keywords:  Astrocyte; astrogliosis; biomarker; functional considerations; reactive astrocytes; traumatic brain injury

Mesh:

Year:  2019        PMID: 31321963     DOI: 10.31083/j.jin.2019.02.110

Source DB:  PubMed          Journal:  J Integr Neurosci        ISSN: 0219-6352            Impact factor:   2.117


  6 in total

Review 1.  Molecular mechanisms and signaling pathways of reactive astrocytes responding to traumatic brain injury.

Authors:  Jiatong Li; Xiaoxuan Wang; Song Qin
Journal:  Histol Histopathol       Date:  2021-04-13       Impact factor: 2.303

2.  A new ketogenic formulation improves functional outcome and reduces tissue loss following traumatic brain injury in adult mice.

Authors:  Orli Thau-Zuchman; Linda Svendsen; Simon C Dyall; Ursula Paredes-Esquivel; Molly Rhodes; John V Priestley; René G Feichtinger; Barbara Kofler; Susanne Lotstra; J Martin Verkuyl; Robert J Hageman; Laus M Broersen; Nick van Wijk; Jose P Silva; Jordi L Tremoleda; Adina T Michael-Titus
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

Review 3.  Astrocytes: a double-edged sword in neurodegenerative diseases.

Authors:  Zhi-Bin Ding; Li-Juan Song; Qing Wang; Gajendra Kumar; Yu-Qing Yan; Cun-Gen Ma
Journal:  Neural Regen Res       Date:  2021-09       Impact factor: 5.135

4.  Beyond New Neurons in the Adult Hippocampus: Imipramine Acts as a Pro-Astrogliogenic Factor and Rescues Cognitive Impairments Induced by Stress Exposure.

Authors:  Ana R Machado-Santos; Eduardo Loureiro-Campos; Patrícia Patrício; Bruna Araújo; Nuno Dinis Alves; António Mateus-Pinheiro; Joana Sofia Correia; Mónica Morais; João M Bessa; Nuno Sousa; Ana J Rodrigues; João Filipe Oliveira; Luísa Pinto
Journal:  Cells       Date:  2022-01-24       Impact factor: 6.600

5.  Cannabidiol Reduces Short- and Long-Term High Glutamate Release after Severe Traumatic Brain Injury and Improves Functional Recovery.

Authors:  Cindy Santiago-Castañeda; Saúl Huerta de la Cruz; Christopher Martínez-Aguirre; Sandra Adela Orozco-Suárez; Luisa Rocha
Journal:  Pharmaceutics       Date:  2022-08-02       Impact factor: 6.525

Review 6.  Astrocytic modulation of potassium under seizures.

Authors:  Fushun Wang; Xiaoming Qi; Jun Zhang; Jason H Huang
Journal:  Neural Regen Res       Date:  2020-06       Impact factor: 5.135

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.